HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yves Poulin Selected Research
Yves Poulin Research Topics
Disease
50
Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 07/2004
7
Acne Vulgaris
06/2011 - 07/2002
6
Atopic Dermatitis (Atopic Eczema)
01/2022 - 04/2015
5
Infections
05/2022 - 06/2007
5
Inflammation (Inflammations)
01/2020 - 01/2006
4
Pruritus (Itching)
01/2020 - 08/2010
3
Eczema
01/2020 - 12/2016
2
Dermatitis
09/2019 - 08/2010
2
Necrosis
01/2018 - 11/2017
2
Hypertension (High Blood Pressure)
01/2017 - 07/2012
1
Neoplasms (Cancer)
05/2022
1
Oral Lichen Planus
09/2019
1
Vitiligo
09/2019
1
Cutaneous Lupus Erythematosus
09/2019
1
Seborrheic Dermatitis
09/2019
1
Localized Scleroderma (Morphea)
09/2019
1
Contact Dermatitis (Eczema, Contact)
09/2019
1
Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
09/2019
1
Nasopharyngitis
01/2019
1
Diarrhea
01/2019
1
Headache (Headaches)
01/2019
1
Nausea
01/2019
1
Rheumatoid Arthritis
01/2017
1
Chronic Disease (Chronic Diseases)
01/2017
1
Injection Site Reaction
12/2016
1
Conjunctivitis
12/2016
1
Diabetes Mellitus
09/2015
1
Psoriatic Arthritis
09/2015
1
Skin Neoplasms (Skin Cancer)
05/2015
1
Tetanus
10/2013
1
Heart Diseases (Heart Disease)
07/2012
1
Hypercholesterolemia
07/2012
1
Chemical and Drug Induced Liver Injury
03/2010
1
Crohn Disease (Crohn's Disease)
07/2009
1
Joint Diseases (Joint Disease)
07/2009
1
Hidradenitis Suppurativa
07/2009
1
Pyoderma Gangrenosum
07/2009
1
Actinic Keratosis
11/2007
Drug/Important Bio-Agent (IBA)
11
Etanercept (Enbrel)
FDA Link
01/2019 - 01/2006
10
Biological Products
IBA
01/2021 - 09/2004
9
Adalimumab (Humira)
FDA Link
01/2019 - 09/2009
6
Infliximab (Remicade)
FDA Link
01/2019 - 01/2006
5
Ustekinumab (CNTO 1275)
FDA Link
01/2019 - 09/2009
4
Pharmaceutical Preparations
IBA
05/2022 - 07/2009
4
Methotrexate (Mexate)
FDA Link
Generic
01/2021 - 04/2011
4
Prostaglandins A
IBA
01/2019 - 09/2006
3
pimecrolimus (Elidel)
FDA Link
09/2019 - 08/2010
3
Cytokines
IBA
01/2018 - 07/2014
3
Interleukin-17 (Interleukin 17)
IBA
09/2017 - 07/2014
3
Clobetasol (Clobetasol Propionate)
FDA Link
Generic
05/2010 - 07/2004
3
Alefacept (Amevive)
FDA Link
12/2009 - 08/2004
3
efalizumab (Raptiva)
FDA Link
01/2006 - 01/2006
2
Vaccines
IBA
05/2022 - 10/2013
2
dupilumab
IBA
01/2022 - 12/2016
2
Interleukin-23 (Interleukin 23)
IBA
01/2021 - 01/2018
2
apremilast
IBA
11/2020 - 01/2019
2
Calcineurin Inhibitors
IBA
09/2019 - 03/2006
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2018 - 07/2009
2
secukinumab
IBA
03/2018 - 07/2015
2
Monoclonal Antibodies
IBA
01/2018 - 12/2016
2
Immunoglobulin G (IgG)
IBA
01/2018 - 01/2006
2
Interleukins
IBA
07/2015 - 07/2014
2
Benzoyl Peroxide
FDA Link
Generic
06/2011 - 08/2009
2
Adapalene (Differin)
FDA Link
Generic
06/2011 - 08/2009
2
Proteins (Proteins, Gene)
FDA Link
12/2007 - 09/2006
2
XP-828l
IBA
12/2007 - 09/2006
2
Spironolactone (Aldactone)
FDA Link
Generic
01/2004 - 07/2002
2
Flutamide (Eulexin)
FDA Link
Generic
01/2004 - 07/2002
2
Cyproterone Acetate
IBA
01/2004 - 07/2002
1
tildrakizumab
IBA
01/2021
1
PF-06700841
IBA
12/2020
1
nemolizumab
IBA
01/2020
1
ixekizumab
IBA
01/2020
1
Immunoglobulin A (IgA)
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Ointments (Pastes)
IBA
09/2019
1
Tacrolimus (Prograf)
FDA Link
Generic
09/2019
1
Steroids
IBA
09/2019
1
Tumor Necrosis Factor Inhibitors
IBA
01/2019
1
Biomarkers (Surrogate Marker)
IBA
01/2019
1
Certolizumab Pegol
FDA Link
08/2018
1
risankizumab
IBA
01/2018
1
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
12/2016
1
Interleukin-4 (Interleukin 4)
IBA
12/2016
1
Interleukin-13
IBA
12/2016
1
Antibodies
IBA
07/2015
1
Chemokines
IBA
07/2014
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
10/2013
1
Lipids
IBA
07/2012
1
calcipotriene (calcipotriol)
FDA Link
Generic
09/2008
1
N 556
IBA
09/2008
1
Betamethasone (Celestone)
FDA Link
09/2008
Therapy/Procedure
22
Therapeutics
05/2022 - 01/2004
8
Phototherapy (Light Therapy)
11/2020 - 09/2004
7
Biological Therapy
01/2021 - 01/2006
2
Oral Administration
12/2007 - 09/2006
1
Duration of Therapy
01/2021
1
Subcutaneous Injections
01/2020
1
Secondary Prevention
05/2015
1
Withholding Treatment
06/2014